Royal Bank of Canada’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Royal Bank of Canada’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-20,130	Closed	-$23K	–	7283
2017 Q3	$23K	Buy	20,130 +36	+0.2%	+$39	﹤0.01%	5890
2017 Q2	$24K	Hold	20,094	–	–	﹤0.01%	5476
2017 Q1	$26K	Buy	20,094 +6,850	+52%	+$8.72K	﹤0.01%	5503
2016 Q4	$28K	Buy	13,244 +10,000	+308%	+$23.3K	﹤0.01%	5593
2016 Q3	$9K	Sell	3,244 -49	-1%	-$122	﹤0.01%	5834
2016 Q2	$6K	Buy	+3,293	New	+$8.66K	﹤0.01%	5925
2014 Q3	–	Sell	-2	Closed	–	–	6252
2014 Q2	$0	Hold	2	–	–	﹤0.01%	6283
2014 Q1	$0	Buy	+2	New	+$29	﹤0.01%	6286

Royal Bank of Canada's OCRX Position: Q4 2017 in Review

Royal Bank of Canada sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 20,130 shares — an estimated $23K sold.

Royal Bank of Canada first reported a position in OCRX in Q1 2014 and held it in 8 quarters. The position peaked at $28K in Q4 2016. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

Royal Bank of Canada reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Royal Bank of Canada sold 20,130 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $23K.
Royal Bank of Canada first reported a position in Ocera Therapeutics, Inc. in Q1 2014 and held it in 8 quarters.
Royal Bank of Canada's Ocera Therapeutics, Inc. position peaked at $28K in Q4 2016.
0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.